New Delhi metallo-β-lactamase-1: Local acquisition in Ontario, Canada, and challenges in detection

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 11, 2011, Pages 1257-1261

  Kus, Julianne V ^a,b   Tadros, Manal ^b,c   Simor, Andrew ^b,c   Low, Donald E ^a,d   McGeer, Allison J ^a,b   Willey, Barbara M ^a   Larocque, Cindy ^a   Pike, Karen ^a   Edwards, Iris Ann ^a   Dedier, Helen ^a   Melano, Roberto ^b,d   Boyd, David A ^e   Mulvey, Michael R ^e   Louie, Lisa ^c   Okeahialam, Christopher ^f   Bayley, Mark ^b,f   Whitehead, Cynthia ^b,f   Richardson, Denyse ^b,f   Carr, Lesley ^b,c   Jinnah, Fatema ^c   Poutanen, Susan M ^a,b   more..

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d PUBLIC HEALTH ONTARIO   (Canada)

^e PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^f TORONTO REHABILITATION INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; CEFALEXIN; CEFALOTIN; CEFTRIAXONE; ERTAPENEM; MEROPENEM; METALLO BETA LACTAMASE; METRONIDAZOLE; NEW DELHI METALLO BETA LACTAMASE 1; UNCLASSIFIED DRUG;

ACUTE CHOLECYSTITIS; AGED; ANAMNESIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BACTERIURIA; CANADA; CASE REPORT; FEMALE; HOSPITAL ADMISSION; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORGANELLA MORGANII; NONHUMAN; PROTEIN ANALYSIS; PROTEUS MIRABILIS; STROKE; TERTIARY HEALTH CARE;

EID: 80051574564     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.110477     Document Type: Article

References (22)

1. Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-β-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009;53:5046-54.
2. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10:597-602.
3. Pillai DR, McGeer A, Low DE. New Delhi metallo-β-lactamase-1 in Enterobacteriaceae: emerging resistance. CMAJ 2011; 183:59-64.
4. Mulvey MR, Grant JM, Plewes K, et al. New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerg Infect Dis 2011;17:103-6.
5. Peirano G, Ahmed-Bentley J, Woodford N, et al. New Delhi metallo-β-lactamase from traveler returning to Canada. Emerg Infect Dis 2011;17:242-4.
6. Tijet N, Alexander DC, Richardson D, et al. New Delhi metallo-β-lactamase, Ontario, Canada. Emerg Infect Dis 2011; 17: 306- 7.
7. Guidance: Infection prevention and control measures for healthcare workers in all healthcare settings: Carbapenem-resistant Gram-negative bacilli. Ottawa (ON): Public Health Agency of Canada; 2010. Available: www.phac-aspc.gc.ca/nois-sinp/guide/ipcm-mpci/ipcm-mpci-eng.php. (accessed 2011 Mar. 5).
8. Guidance on carbapenem resistance producers. London (UK): UK Health Protection Agency; 2011. Available: www.hpa.org.uk/Topics/InfectiousDiseases/ InfectionsAZ/CarbapenemResistance/GuidanceOnCarbapenamProducers/ (accessed 2011 Mar. 5).
9. Carmeli Y, Akova M, Cornaglia G, et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010;16:102- 11.
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. CLSI document M100-S21. Wayne (PA): The Institute; 2011.
11. Detection of Enterobacteriaceae isolates carrying metallo-β- lactamase - United States, 2010. MMWR Morb Mortal Wkly Rep 2010;59:750.
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. CLSI document M100-S20. Wayne (PA): The Institute; 2010.
13. Seah C, Low DE, Patel SN, et al. Comparative evaluation of a chromogenic agar medium, the modified Hodge test, and a battery of meropenem-inhibitor discs for detection of carbapenemase activity in Enterobacteriaceae. J Clin Microbiol 2011; 49: 1965-9.
14. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) Clinical Breakpoints. Basel (Switzerland): European Society of Clinical Microbiology and Infectious Diseases; 2011. Available: www.eucast.org/clinical- breakpoints (accessed 2011 May 18).
15. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - eighth edition. CLSI document M07-A8. Wayne (PA): The Institute; 2009.
16. Pr Tygacil® tigecycline for injection. Kirkland (QC): Pfizer Canada; 2010.
17. Murray BE, Singh KV, Heath JD, et al. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 1990;28:2059-63. (Pubitemid 20260989)
18. Reekers JA, Lee MJ, Belli AM, et al. Cardiovascular and Interventional Radiological Society of Europe commentary on the treatment of chronic cerebrospinal venous insufficiency. Cardiovasc Intervent Radiol 2011;34:1-2.
19. Nicolle LE, Bradlely S, Colgan R, et al. Infectious Diseases Society of America Guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005;40:643-54. (Pubitemid 40381336)
20. Kus J, Willey BM, Melano R, et al. Failure of the modified Hodge test (MHT) to detect New Delhi metallo-β-lactamase-1 (NDM-1) carbapenemases. Can J Infect Dis Med Microbiol 2011; 22 (Suppl A):41A-42A (Poster No. SP11).
21. Mochon AB, Garner OB, Hindler JA, et al. New Delhi metallo-β- lactamase (NDM-1)-producing Klebsiella penumoniae: case report and laboratory detection strategies. J Clin Microbiol 2011; 49:1667-70.
22. Castanheira M, Deshpande LM, Mathai D, et al. Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother 2011; 55:1274-8.